Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D&T) Committee Meeting Results for: June 10, 2015

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Afrezza	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Bunavail	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Qudexy XR	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Toujeo	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Viekera Pak	New Drug Appeal	Require Prior Approval	Prior Approval Required

Footer